UY33915A - Uso de nifuratel para tratar infecciones causadas por especies de clostridium - Google Patents
Uso de nifuratel para tratar infecciones causadas por especies de clostridiumInfo
- Publication number
- UY33915A UY33915A UY0001033915A UY33915A UY33915A UY 33915 A UY33915 A UY 33915A UY 0001033915 A UY0001033915 A UY 0001033915A UY 33915 A UY33915 A UY 33915A UY 33915 A UY33915 A UY 33915A
- Authority
- UY
- Uruguay
- Prior art keywords
- nifuratel
- infections caused
- treat infections
- clostridium species
- treat
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención está dirigida al uso de nifuratel, o una sal fisiológicamente aceptable del mismo, para tratar infecciones causadas por especies de bacterias del género Clostridium. La invención también está dirigida al uso de nifuratel para tratar la infección de Clostridium difficile (CDI) y en particular Clostridium difficile asociada con diarrea (CDAD).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11155283A EP2491929A1 (en) | 2011-02-22 | 2011-02-22 | Use of Nifuratel to treat infections caused by Clostridium species |
Publications (1)
Publication Number | Publication Date |
---|---|
UY33915A true UY33915A (es) | 2012-04-30 |
Family
ID=44059064
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001033915A UY33915A (es) | 2011-02-22 | 2012-02-22 | Uso de nifuratel para tratar infecciones causadas por especies de clostridium |
Country Status (24)
Country | Link |
---|---|
EP (2) | EP2491929A1 (es) |
KR (1) | KR20140021525A (es) |
CN (1) | CN103384523B (es) |
AR (1) | AR085266A1 (es) |
BR (1) | BR112013015974A2 (es) |
CL (1) | CL2013002098A1 (es) |
CY (1) | CY1116210T1 (es) |
DK (1) | DK2678015T3 (es) |
EA (1) | EA025645B1 (es) |
ES (1) | ES2529210T3 (es) |
GE (1) | GEP20156264B (es) |
HK (1) | HK1187553A1 (es) |
HR (1) | HRP20150141T1 (es) |
ME (1) | ME02056B (es) |
MX (1) | MX341213B (es) |
PL (1) | PL2678015T3 (es) |
PT (1) | PT2678015E (es) |
RS (1) | RS53739B1 (es) |
SI (1) | SI2678015T1 (es) |
SM (1) | SMT201500039B (es) |
TW (1) | TWI536989B (es) |
UA (1) | UA113159C2 (es) |
UY (1) | UY33915A (es) |
WO (1) | WO2012113594A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102885793B (zh) * | 2012-10-15 | 2014-08-20 | 山东罗欣药业股份有限公司 | 一种硝呋太尔组合物片剂及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003000255A1 (en) * | 2001-06-25 | 2003-01-03 | Essential Therapeutics, Inc. | Novel nitrofuran-containing heterocyclic compounds and uses thereof |
EP2243482A1 (en) | 2009-04-20 | 2010-10-27 | Polichem SA | Use of nifuratel to treat infections caused by atopobium species |
-
2011
- 2011-02-22 EP EP11155283A patent/EP2491929A1/en not_active Withdrawn
-
2012
- 2012-01-19 BR BR112013015974A patent/BR112013015974A2/pt not_active IP Right Cessation
- 2012-01-19 PT PT127004877T patent/PT2678015E/pt unknown
- 2012-01-19 ME MEP-2015-29A patent/ME02056B/me unknown
- 2012-01-19 CN CN201280009547.7A patent/CN103384523B/zh not_active Expired - Fee Related
- 2012-01-19 UA UAA201310071A patent/UA113159C2/uk unknown
- 2012-01-19 RS RS20150026A patent/RS53739B1/en unknown
- 2012-01-19 WO PCT/EP2012/050759 patent/WO2012113594A1/en active Application Filing
- 2012-01-19 GE GEAP201213233A patent/GEP20156264B/en unknown
- 2012-01-19 MX MX2013009686A patent/MX341213B/es active IP Right Grant
- 2012-01-19 ES ES12700487.7T patent/ES2529210T3/es active Active
- 2012-01-19 PL PL12700487T patent/PL2678015T3/pl unknown
- 2012-01-19 EA EA201370179A patent/EA025645B1/ru not_active IP Right Cessation
- 2012-01-19 KR KR1020137017417A patent/KR20140021525A/ko not_active Application Discontinuation
- 2012-01-19 EP EP12700487.7A patent/EP2678015B1/en active Active
- 2012-01-19 DK DK12700487.7T patent/DK2678015T3/en active
- 2012-01-19 SI SI201230134T patent/SI2678015T1/sl unknown
- 2012-02-16 AR ARP120100532A patent/AR085266A1/es unknown
- 2012-02-20 TW TW101105436A patent/TWI536989B/zh not_active IP Right Cessation
- 2012-02-22 UY UY0001033915A patent/UY33915A/es not_active Application Discontinuation
-
2013
- 2013-07-22 CL CL2013002098A patent/CL2013002098A1/es unknown
-
2014
- 2014-01-23 HK HK14100747.0A patent/HK1187553A1/xx not_active IP Right Cessation
-
2015
- 2015-02-04 HR HRP20150141AT patent/HRP20150141T1/hr unknown
- 2015-02-13 SM SM201500039T patent/SMT201500039B/xx unknown
- 2015-02-25 CY CY20151100196T patent/CY1116210T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
SMT201500039B (it) | 2015-03-05 |
PL2678015T3 (pl) | 2015-04-30 |
GEP20156264B (en) | 2015-03-25 |
EA201370179A1 (ru) | 2014-03-31 |
KR20140021525A (ko) | 2014-02-20 |
SI2678015T1 (sl) | 2015-03-31 |
ME02056B (me) | 2015-05-20 |
MX341213B (es) | 2016-08-11 |
HRP20150141T1 (en) | 2015-03-13 |
CL2013002098A1 (es) | 2014-06-06 |
BR112013015974A2 (pt) | 2018-06-05 |
EA025645B1 (ru) | 2017-01-30 |
EP2678015A1 (en) | 2014-01-01 |
MX2013009686A (es) | 2013-12-06 |
ES2529210T3 (es) | 2015-02-18 |
UA113159C2 (xx) | 2016-12-26 |
AR085266A1 (es) | 2013-09-18 |
CN103384523B (zh) | 2015-04-29 |
TWI536989B (zh) | 2016-06-11 |
DK2678015T3 (en) | 2015-01-26 |
CY1116210T1 (el) | 2017-02-08 |
HK1187553A1 (en) | 2014-04-11 |
EP2678015B1 (en) | 2014-11-26 |
EP2491929A1 (en) | 2012-08-29 |
PT2678015E (pt) | 2015-02-10 |
WO2012113594A1 (en) | 2012-08-30 |
TW201309292A (zh) | 2013-03-01 |
CN103384523A (zh) | 2013-11-06 |
RS53739B1 (en) | 2015-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2015003120A1 (es) | Cepas bacterianas que poseen actividad antimicrobiana y composiciones de control biológico que las contienen | |
CO2020016675A2 (es) | Tiofenocarboxamidas sustituidas y análogos como agentes antibacterianos | |
MX2016009898A (es) | Tratamientos para acne resistente. | |
GT201400033A (es) | Pirimidinas anilladas sustituidas y uso de las mismas | |
CO6751260A2 (es) | Vacunas basadas en omv contra infecciones por burkholderia | |
ECSP14024082A (es) | Material no viable derivado de probióticos para la prevención y tratamiento de infecciones | |
EA201591761A1 (ru) | Композиции на основе наночастиц | |
BR112012018021A2 (pt) | antídotos anticoagulantes. | |
MX354988B (es) | Formulaciones de anticuerpo y metodos. | |
CL2015000986A1 (es) | Composiciones útiles en el tratamiento y control de enfermedades en plantas y métodos asociados. | |
MX361945B (es) | Metodos y composiciones de fermentacion bacteriana. | |
UA111972C2 (uk) | Вагінальна таблетка, яка містить рифаксимін, спосіб її виготовлення та застосування для лікування вагінальних інфекцій | |
PE20140233A1 (es) | Nuevo bacteriofago y composicion antibacteriana que comprende el mismo | |
EA201390639A1 (ru) | Производные 2-пиперазин-1-ил-4н-1,3-бензотиазин-4-она и их применение для лечения инфекций у млекопитающих | |
CL2012002902A1 (es) | Cepas de bacteriofagos especifica contra bacterias pertenecientes al genero vibrio para la profilaxis y terapia de vibrio anguillarum; y composicion antibacteriana que comprende dicha cepas. | |
MX2017009094A (es) | Derivado de polimixina y usos del mismo. | |
BR112014030025A2 (pt) | composições de polissacarídeo e métodos de uso | |
EA201391396A1 (ru) | Макроциклические соединения и способы их получения | |
MX2013004906A (es) | Nuevos inhibidores especificos de la proteasa ns3 de hcv. | |
AR094810A1 (es) | Parvovirus porcino 5b, métodos de uso y vacuna | |
PL386175A1 (pl) | Nowe szczepy bakteriofagów do leczenia zakażeń bakteryjnych, zwłaszcza szczepami bakterii lekoopornych rodzaju Enterococcus | |
UY33915A (es) | Uso de nifuratel para tratar infecciones causadas por especies de clostridium | |
CR20120166A (es) | Composiciones y productos antimicrobianos | |
CO6831974A2 (es) | Usos, métodos y composiciones biológicas del genero paecilomyces para el control, prevención y erradicación de fitoparásitos en cultivos de solanáceas | |
CO2019006311A2 (es) | N-acetilcisteína para su uso como agente antibacteriano |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20200910 |